Equitable Trust’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Sell
2,757
-2,359
-46% -$242K 0.01% 422
2025
Q4
$543K Hold
5,116
0.02% 306
2025
Q3
$650K Hold
5,116
0.03% 288
2025
Q2
$627K Hold
5,116
0.03% 289
2025
Q1
$518K Sell
5,116
-213
-4% -$20.8K 0.03% 302
2024
Q4
$492K Sell
5,329
-500
-9% -$49.1K 0.03% 324
2024
Q3
$563K Hold
5,829
0.04% 289
2024
Q2
$500K Sell
5,829
-600
-9% -$50.4K 0.03% 300
2024
Q1
$531K Buy
6,429
+2,634
+69% +$193K 0.04% 293
2023
Q4
$253K Hold
3,795
0.02% 374
2023
Q3
$255K Hold
3,795
0.02% 365
2023
Q2
$257K Hold
3,795
0.02% 358
2023
Q1
$205K Sell
3,795
-403
-10% -$23.5K 0.02% 384
2022
Q4
$251K Buy
+4,198
New +$228K 0.02% 356
2021
Q4
Sell
-21,638
Closed -$1.29M 378
2021
Q3
$1.29M Buy
+21,638
New +$1.36M 0.08% 164

Other funds holding EHC

Equitable Trust's EHC Position: Q1 2026 in Review

Equitable Trust reduced its Encompass Health (EHC) stake by 46% in Q1 2026, selling an estimated $242K and leaving 2,757 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #422.

Equitable Trust first reported a position in EHC in Q3 2021 and has held it in 15 quarters since. The position peaked at $1.29M in Q3 2021. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Equitable Trust held 2,757 shares of Encompass Health worth $267K as of Q1 2026.
  • Equitable Trust sold 2,359 Encompass Health shares in Q1 2026, an estimated $242K.
  • Encompass Health made up 0.01% of Equitable Trust's portfolio in Q1 2026, its #422 holding.
  • Equitable Trust first reported a position in Encompass Health in Q3 2021 and has held it in 15 quarters since.
  • Equitable Trust's Encompass Health position peaked at $1.29M in Q3 2021.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.